The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation
- PMID: 11193237
- DOI: 10.1007/s001980070002
The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation
Similar articles
-
Markers of bone turnover for the prediction of fracture risk.Osteoporos Int. 2000;11 Suppl 6:S55-65. doi: 10.1007/s001980070006. Osteoporos Int. 2000. PMID: 11193240 Review. No abstract available.
-
Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs.Osteoporos Int. 2000;11 Suppl 6:S66-76. doi: 10.1007/s001980070007. Osteoporos Int. 2000. PMID: 11193241 Review. No abstract available.
-
Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.Drugs. 2006;66(16):2031-58. doi: 10.2165/00003495-200666160-00001. Drugs. 2006. PMID: 17112299 Review.
-
The elusive concept of bone quality.Curr Osteoporos Rep. 2004 Sep;2(3):97-100. doi: 10.1007/s11914-004-0017-z. Curr Osteoporos Rep. 2004. PMID: 16036089 Review.
-
The treatment of osteoporosis. Antiresorptive therapy.Clin Lab Med. 2000 Sep;20(3):603-22, viii. Clin Lab Med. 2000. PMID: 10986624 Review.
Cited by
-
Dysregulation of ossification-related miRNAs in circulating osteogenic progenitor cells obtained from patients with aortic stenosis.Clin Sci (Lond). 2016 Jul 1;130(13):1115-24. doi: 10.1042/CS20160094. Epub 2016 Apr 14. Clin Sci (Lond). 2016. PMID: 27129184 Free PMC article.
-
Establishing reference intervals for bone turnover markers in the healthy shanghai population and the relationship with bone mineral density in postmenopausal women.Int J Endocrinol. 2013;2013:513925. doi: 10.1155/2013/513925. Epub 2013 Feb 27. Int J Endocrinol. 2013. PMID: 23533403 Free PMC article.
-
Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: a consensus advice from an Austrian working group.Wien Med Wochenschr. 2012 Nov;162(21-22):464-77. doi: 10.1007/s10354-012-0133-9. Epub 2012 Aug 14. Wien Med Wochenschr. 2012. PMID: 22890523
-
Review of guidelines for testing and treatment of osteoporosis.Curr Osteoporos Rep. 2003 Sep;1(2):59-65. doi: 10.1007/s11914-003-0010-y. Curr Osteoporos Rep. 2003. PMID: 16036066 Review.
-
The effect of PTH(1-84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial.Osteoporos Int. 2011 Sep;22(9):2529-37. doi: 10.1007/s00198-010-1460-6. Epub 2010 Oct 30. Osteoporos Int. 2011. PMID: 21052638 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical